(DDD) 3D Systems - Overview
Sector: Technology | Industry: Computer Hardware | Exchange: NYSE (USA) | Market Cap: 463m USD | Total Return: 99.4% in 12m
Avg Turnover: 8.72M
Qual. Beats: 1
Rev. Trend: -99.1%
Qual. Beats: 0
Warnings
Earnings expected to drop: P/E 7.2 → Forward 22.5
Altman Z'' -10.06 < 1.0 - financial distress zone
Choppy
Tailwinds
Rs Leader, Confidence
3D Systems Corporation is a diversified additive manufacturing provider headquartered in Rock Hill, South Carolina. The company operates through two primary segments: Healthcare Solutions and Industrial Solutions. Its portfolio includes hardware technologies such as stereolithography (SLA), direct metal printing, and bioprinting, alongside a proprietary suite of software platforms including 3DXpert and the Oqton operating system.
The business model relies on a razor-and-blade strategy, where the initial sale of 3D printing systems generates recurring revenue through the ongoing supply of specialized materials like polymers, metals, and biocompatible dental resins. As a pioneer in the sector, 3D Systems serves high-precision industries including aerospace, defense, and semiconductor manufacturing, where additive processes reduce material waste compared to traditional subtractive machining.
The additive manufacturing industry is currently shifting from rapid prototyping toward full-scale production applications, which requires heightened focus on material science and software integration. Investors evaluating this sector may find ValueRays comparative data useful for deeper analysis. 3D Systems maintains a global footprint across the Americas, EMEA, and Asia Pacific, utilizing a mix of direct sales and distributor networks to reach its industrial and medical client base.
- Healthcare segment demand for dental and orthopedic applications drives revenue growth
- Industrial capital expenditure cycles impact additive manufacturing hardware sales volume
- Expansion of bioprinting technology portfolio influences long-term valuation premiums
- Gross margin performance depends on high-margin proprietary material sales mix
- Operational restructuring and cost reduction initiatives dictate path to profitability
| Net Income: 62.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.14 > 0.02 and ΔFCF/TA -1.93 > 1.0 |
| NWC/Revenue: 56.01% < 20% (prev 59.73%; Δ -3.72% < -1%) |
| CFO/TA -0.12 > 3% & CFO -61.3m > Net Income 62.4m |
| Net Debt (70.0m) to EBITDA (93.1m): 0.75 < 3 |
| Current Ratio: 2.76 > 1.5 & < 3 |
| Outstanding Shares: last quarter (143.3m) vs 12m ago 8.15% < -2% |
| Gross Margin: 33.93% > 18% (prev 0.36%; Δ 3.36k% > 0.5%) |
| Asset Turnover: 70.75% > 50% (prev 74.01%; Δ -3.26% > 0%) |
| Interest Coverage Ratio: 10.70 > 6 (EBITDA TTM 93.1m / Interest Expense TTM 6.75m) |
| A: 0.42 (Total Current Assets 340.7m - Total Current Liabilities 123.4m) / Total Assets 513.1m |
| B: -2.61 (Retained Earnings -1.34b / Total Assets 513.1m) |
| C: 0.13 (EBIT TTM 72.2m / Avg Total Assets 548.2m) |
| D: -4.98 (Book Value of Equity -1.39b / Total Liabilities 278.8m) |
| Altman-Z'' = -10.06 = D |
| DSRI: 0.92 (Receivables 86.2m/104.7m, Revenue 387.9m/431.8m) |
| GMI: 1.06 (GM 33.93% / 36.12%) |
| AQI: 1.19 (AQ_t 0.14 / AQ_t-1 0.12) |
| SGI: 0.90 (Revenue 387.9m / 431.8m) |
| TATA: 0.24 (NI 62.4m - CFO -61.3m) / TA 513.1m) |
| Beneish M = -2.75 (Cap -4..+1) = A |
As of May 26, 2026, the stock is trading at USD 3.15 with a total of 4,527,900 shares traded.
Over the past week, the price has changed by +4.30%,
over one month by +42.53%,
over three months by +52.17% and
over the past year by +99.37%.
3D Systems has received a consensus analysts rating of 3.50. Therefore, it is recommended to hold DDD.
- StrongBuy: 1
- Buy: 0
- Hold: 3
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 4 | 27% |
P/E Trailing = 7.1591
P/E Forward = 22.5225
P/S = 1.1933
P/B = 1.9752
P/EG = 0.8503
Revenue TTM = 387.9m USD
EBIT TTM = 72.2m USD
EBITDA TTM = 93.1m USD
Long Term Debt = 86.8m USD (from longTermDebt, last quarter)
Short Term Debt = 14.9m USD (from shortTermDebt, last quarter)
Debt = 155.1m USD (corrected: LT Debt 86.8m + ST Debt 14.9m) + Leases 53.4m
Net Debt = 70.0m USD (calculated: Debt 155.1m - CCE 85.1m)
Enterprise Value = 532.9m USD (462.9m + Debt 155.1m - CCE 85.1m)
Interest Coverage Ratio = 10.70 (Ebit TTM 72.2m / Interest Expense TTM 6.75m)
EV/FCF = -7.56x (Enterprise Value 532.9m / FCF TTM -70.5m)
FCF Yield = -13.22% (FCF TTM -70.5m / Enterprise Value 532.9m)
FCF Margin = -18.16% (FCF TTM -70.5m / Revenue TTM 387.9m)
Net Margin = 16.10% (Net Income TTM 62.4m / Revenue TTM 387.9m)
Gross Margin = 33.93% ((Revenue TTM 387.9m - Cost of Revenue TTM 256.3m) / Revenue TTM)
Gross Margin QoQ = 35.42% (prev 30.28%)
Tobins Q-Ratio = 1.04 (Enterprise Value 532.9m / Total Assets 513.1m)
Interest Expense / Debt = 4.35% (Interest Expense 6.75m / Debt 155.1m)
Taxrate = 33.23% (14.9m / 44.8m)
NOPAT = 48.2m (EBIT 72.2m * (1 - 33.23%))
Current Ratio = 2.76 (Total Current Assets 340.7m / Total Current Liabilities 123.4m)
Debt / Equity = 0.66 (Debt 155.1m / totalStockholderEquity, last quarter 234.3m)
Debt / EBITDA = 0.75 (Net Debt 70.0m / EBITDA 93.1m)
Debt / FCF = -0.99 (negative FCF - burning cash) (Net Debt 70.0m / FCF TTM -70.5m)
Total Stockholder Equity = 234.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 11.39% (Net Income 62.4m / Total Assets 513.1m)
RoE = 3.97% (Net Income TTM 62.4m / Total Stockholder Equity 1.57b)
RoCE = 4.36% (EBIT 72.2m / Capital Employed (Equity 1.57b + L.T.Debt 86.8m))
RoIC = 15.09% (NOPAT 48.2m / Invested Capital 319.5m)
WACC = 11.42% (E(462.9m)/V(618.0m) * Re(14.27%) + D(155.1m)/V(618.0m) * Rd(4.35%) * (1-Tc(0.33)))
Discount Rate = 14.27% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: -11.11 | Cagr: 4.41%
[DCF] Fair Price = unknown (Cash Flow -70.5m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 1.28 | # QB: 1
Revenue Correlation: -99.09 | Revenue CAGR: -10.42% | SUE: 0.75 | # QB: 0
EPS current Quarter (2026-06-30): EPS=-0.05 | Chg30d=N/A | Revisions=+43% | Analysts=4
EPS next Quarter (2026-09-30): EPS=-0.05 | Chg30d=N/A | Revisions=+14% | Analysts=4
EPS current Year (2026-12-31): EPS=-0.14 | Chg30d=N/A | Revisions=+43% | GrowthEPS=+60.8% | GrowthRev=+0.6%
EPS next Year (2027-12-31): EPS=-0.13 | Chg30d=N/A | Revisions=+50% | GrowthEPS=+12.1% | GrowthRev=+4.2%
[Analyst] Revisions Ratio: +50%